Loading stock data…
MASS
$6.58-0.23 (-3.38%)
Market OpenUpdated 1:05 PM EDT
908 Devices Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
908 Devices Inc. in the Healthcare sector is trading at $6.58. The stock is currently 30% below its 52-week high of $9.34, remaining 1.3% below its 200-day moving average. Technical signals show neutral RSI of 30 and bearish MACD signal, explaining why MASS maintains its current current market pressure. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Oversold momentum (RSI 30) — potential for technical mean-reversion
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$6.58
Potential Upside
5%
Whystock Fair Value$6.91
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company's products include MX908, a handheld, battery-powered, and Mass Spec device ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$266.52M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.53
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
13.56%
Volume
Today's trading volume
153,696
Recent News
Asian Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading
Asian equities traded in the US as American depositary receipts were tracking lower Tuesday morning,
908 Devices Calls “Inflection Point,” Targets 15%-20% 2026 Growth on Field Detection Demand
Executives from 908 Devices (NASDAQ:MASS) outlined what they described as an “inflection point” for the company, emphasizing its focus on bringing lab-grade chemical analysis technologies into field-ready handheld and portable devices for public health, safety, and defense use cases. Field-based ch
908 Devices Inc. Q4 2025 Earnings Call Summary
Moby summary of 908 Devices Inc.'s Q4 2025 earnings call
908 Devices Inc (MASS) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
908 Devices Inc (MASS) reports significant revenue growth and strategic moves to enhance operational efficiency and future growth potential.
908 Devices Q4 Earnings Call Highlights
908 Devices (NASDAQ:MASS) reported fourth-quarter and full-year 2025 results that management said reflected continued momentum from its strategic transformation, including stronger adoption of its handheld chemical analysis devices and improved profitability metrics. Fourth-quarter growth driven by